86,100
-1.03%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Dong-A Socio Holdings Co
Its shares trade on KRX under the ticker 000640.KS. It has been listed since 10 February 1970. In the fiscal year to 31 December 2025, it reported revenue of ₩1.43trn and net income of ₩90.94bn. At that date it held total assets of ₩2.08trn and shareholders' equity of ₩1.14trn.
Dong-A Socio Holdings Co., Ltd. manufactures pharmaceutical preparations and products. The company is headquartered in Seoul, Seoul. The firm operates its business through five segments. The Medicine Manufacturing segment is engaged in the manufacture and sale of pharmaceuticals. The main pharmaceuticals include tonic medicines, cold medicines, raw material medicines. The Logistic segment is involved in the freight, courier, car transportation, freight warehousing and leasing business. The Packaging segment is engaged in manufacturing and sale of glass and glass products. The Holding Company segment is engaged in the provision of core companies and management consulting services. The Other segment is engaged in the production and sale of information and communication technology (IT) solutions and agricultural products, as well as real estate development business.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 10 Feb 1970
- Website
- donga.co.kr ↗
Leadership
Pay as last reported
- Mr. Jeong Seok KangChairman, Chief Scientific Officer
- Mr. Min Yeong KimPresident, Chief Executive Officer, Director, since 2017
- Mr. Seung Hyeon GohChief Financial Officer, Assistant Managing Director, since 2021
- Mr. Jae Hun JungVice President
- Mr. Yi Hwan KimAssistant Managing Director
- Mr. Mu Hwan OhAssistant Managing Director, Internal Auditor, since 2023
- Mr. Min Wu ChoDirector
- Mr. Yeong Sam GeumNon-Executive Independent Director
- Mr. Gyeong Bae GwonNon-Executive Independent Director
- Mr. Se Won GwonNon-Executive Independent Director
- Mr. Yeong Jin JungNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dong-A Socio Holdings Co Ltd has a strong market presence and has established itself as a reputable company in the industry. This provides them with a competitive advantage over new entrants and allows for stronger brand recognition.
- The company offers a diverse product range, catering to various customer needs and preferences. This helps Dong-A Socio Holdings Co Ltd attract a wider customer base and reduces the risk of relying heavily on a single product or market segment.
Weaknesses
- Dong-A Socio Holdings Co Ltd heavily relies on the domestic market for its revenue. This makes the company vulnerable to any fluctuations in the local economy, government regulations, or changes in consumer preferences. Diversifying into international markets could mitigate this weakness.
- The company may face challenges in funding expansion plans or research and development projects due to limited financial resources. This could hinder their ability to compete with larger competitors and invest in innovation.
Opportunities
- With the increasing focus on health and wellness, Dong-A Socio Holdings Co Ltd can capitalize on this trend by expanding their portfolio of health-related products. This presents an opportunity to attract new customers and increase market share.
- The company has the potential to expand its operations into international markets. This would not only diversify their revenue streams but also enable them to tap into new customer segments and benefit from global growth opportunities.
Threats
- Dong-A Socio Holdings Co Ltd operates in a highly competitive industry, facing competition from both domestic and international players. The company must continuously innovate and differentiate itself to maintain its market position.
- The company may encounter regulatory and legal challenges, such as compliance with health and safety regulations or intellectual property rights infringement. Non-compliance could result in fines, legal disputes, or damage to the company's reputation.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.